Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Koshi Kumagai"'
Autor:
Yasufumi Koterazawa, Manabu Ohashi, Masaru Hayami, Rie Makuuchi, Satoshi Ida, Koshi Kumagai, Takeshi Sano, Souya Nunobe
Publikováno v:
Gastric Cancer. 26:451-459
Autor:
Toshifumi Yamaguchi, Atsuo Takashima, Kengo Nagashima, Koshi Kumagai, Tatsuya Yamada, Masanori Terashima, Hiroshi Yabusaki, Kazuhiro Nishikawa, Kazuaki Tanabe, Gen Yunome, Yasuyuki Kawachi, Takanobu Yamada, Takeo Fukagawa, Takahiro Kinoshita, Masaya Watanabe, Koshiro Ishiyama, Kentaro Inoue, Narikazu Boku
Publikováno v:
Gastric Cancer. 26:307-316
Autor:
Reiko, Otake, Koshi, Kumagai, Manabu, Ohashi, Rie, Makuuchi, Satoshi, Ida, Takeshi, Sano, Souya, Nunobe
Publikováno v:
Annals of Surgical Oncology. 30:2294-2303
Laparoscopic pylorus-preserving gastrectomy (LPPG) is performed for cT1N0 gastric cancer as a function-preserving surgery, but reflux esophagitis can develop as a mid- to long-term complication postoperatively. We aimed to clarify the incidence rate
Autor:
Yasufumi Koterazawa, Manabu Ohashi, Masaru Hayami, Rie Makuuchi, Satoshi Ida, Koshi Kumagai, Takeshi Sano, Souya Nunobe
Publikováno v:
Gastric Cancer.
Autor:
Daisuke Takahari, Hitoshi Katai, Atsuo Takashima, Naoki Izawa, Naoki Ishizuka, Manabu Ohashi, Shinya Mikami, Takeru Wakatsuki, Izuma Nakayama, Keisho Chin, Satoshi Ida, Koshi Kumagai, Souya Nunobe, Satoru Iwasa, Hirokazu Shoji, Takeyuki Wada, Ayako Doi, Takaki Yoshikawa, Takeshi Sano, Narikazu Boku, Kensei Yamaguchi
Publikováno v:
Gastric Cancer.
Background We investigated the feasibility of perioperative chemotherapy with S-1 and leucovorin (TAS-118) plus oxaliplatin in patients with locally advanced gastric cancer. Methods Patients with clinical T3–4N1–3M0 gastric cancer received four c
Autor:
Kensei Yamaguchi, Rie Makuuchi, Souya Nunobe, Yosuke Kano, Satoshi Ida, Daisuke Takahari, Yusuke Muneoka, Koshi Kumagai, Keisho Chin, Manabu Ohashi, Takeshi Sano
Publikováno v:
European Journal of Surgical Oncology. 47:3097-3104
After curative gastrectomy followed by 1-year adjuvant S-1 monotherapy for pathological stage (pStage) II or III gastric cancer, some patients experience peritoneal, hematogenous, or lymph nodal recurrence. However, risk factors for each recurrence p
Autor:
Takeshi Sano, Masaru Hayami, Satoshi Ida, Shinichiro Atsumi, Souya Nunobe, Motonari Ri, Naoki Ishizuka, Manabu Ohashi, Rie Makuuchi, Koshi Kumagai
Publikováno v:
Journal of Gastric Cancer
Purpose Although dumping symptoms are thought to involve postprandial glycemic changes, postprandial glycemic variability without dumping symptoms remains poorly understood due to the lack of a method that allows the easy and continuous measurement o
Autor:
Reiko Otake, Koshi Kumagai, Manabu Ohashi, Rie Makuuchi, Satoshi Ida, Takeshi Sano, Souya Nunobe
Publikováno v:
Annals of Surgical Oncology. 30:2304-2305
Autor:
Koshi Kumagai, Takeshi Sano
Publikováno v:
Japanese Journal of Clinical Oncology. 51:1024-1027
The American Joint Committee on Cancer and the Union for International Cancer Control have now released the eighth edition of the cancer staging system, which incorporates some major revisions concerning gastric cancer. First, grouping of pathologica
Autor:
Yasufumi Koterazawa, Manabu Ohashi, Masaru Hayami, Rie Makuuchi, Satoshi Ida, Koshi Kumagai, Takeshi Sano, Souya Nunobe
Publikováno v:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 25(5)
In proximal gastrectomy (PG), a longer distal margin (DM) length should be maintained to obtain a pathologically negative DM. However, a shorter DM length is preferred to preserve a large remnant stomach for favorable postoperative outcomes. Evidence